#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • Study of Lutetium (177Lu) Vipivotide Tetraxetan and Ipilimumab for Men with Very High-Risk Prostate Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Long-Term Follow-Up Study of TX200-TR101 for Patients with Kidney Transplant Rejection

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium The Netherlands

  • Study of Atezolizumab and Tiragolumab for Patients with Recurrent or Metastatic PD-L1 Positive Head and Neck Squamous Cell Carcinoma

    Not recruiting

    1 1
    Investigated drugs:
    Czechia France Greece Hungary Poland Spain

  • Study of Subcutaneous Nivolumab for Patients with Previously Treated Advanced or Metastatic Clear Cell Kidney Cancer

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Czechia Finland France Ireland Italy Poland +3

  • Study of Relacorilant and Nab-Paclitaxel for Patients with Advanced, Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Hungary Italy Poland Spain

  • Study on Hydrocortisone and Placebo for Patients with Giant Cell Arteritis or Polymyalgia Rheumatica Experiencing Adrenal Insufficiency Symptoms

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on the Effectiveness and Safety of Golimumab for Children with Moderate to Severe Ulcerative Colitis

    Not recruiting

    1 1 1 1
    Investigated drugs:
    France Italy Poland

  • Study on L19IL2 and L19TNF Treatment Before Surgery for Patients with Advanced Melanoma

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Poland

  • Study of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Spain +1

  • Study on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Germany